CERULISINA DOLORE "1% + 5% EAR DROPS, SOLUTION" 1 DROPPER BOTTLE 10 ML

Name
CERULISINA DOLORE 1% + 5% ear drops, solution
Procaine hydrochloride and phenazone


What is it and what is it for?
CERULISINA DOLORE is a combination of two active ingredients: procaine hydrochloride and phenazone. Procaine hydrochloride belongs to a group of medications called local anesthetics, which relieve pain in the area where they are applied, while phenazone, which belongs to a group of medications called anti-inflammatories and analgesics, reduces inflammation and pain.

This medicine is indicated for the treatment of ear pain (otalgia).

Contact your doctor if you do not feel better or if you feel worse after 1-2 days.


What you need to know before taking the medicine
Do not use CERULISINA DOLORE
- if you are allergic or have had an allergy in the past to procaine hydrochloride, phenazone, other chemically similar substances or any of the other ingredients of this medicine (listed in section 6);
- if you have or have had a perforated eardrum, as side effects may occur in the middle ear.


Warnings and precautions
Talk to your doctor or pharmacist before using CERULISINA DOLORE.

In particular, before using this medicine, consult your doctor who, as a precaution, will check that there is no damage to the eardrum.

CERULISINA DOLORE may cause allergic reactions and irritation at the application site. If this occurs, discontinue use and inform your doctor who will determine appropriate therapy.
Do not use this medicine for prolonged treatments. If you do not notice any noticeable results after a short period of treatment (1-2 days), consult your doctor.

Children
In early childhood, CERULISINA DOLORE is recommended only in case of actual need and not for prolonged treatments.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following may occur with an unknown frequency (the frequency of which cannot be estimated from the available data):
- side effects at the level of the middle ear, in case of a perforation of the eardrum;
- reduction in the number of a type of white blood cells (agranulocytosis) and allergic reactions, including severe ones (anaphylactic reactions), following the passage of this medicine into the blood (systemic absorption).

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.